IRWD (STOCKS)
Ironwood Pharmaceuticals, Inc. - Class A
$4.640000
+0.200000 (+4.50%)
Prev close: $4.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas A. McCourt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $752.39M
- Employees
- 253
- P/E (TTM)
- 28.76
- P/B (TTM)
- -2.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.24 | $0.10 | +0.1380 | +135.29% |
|
Jun 2025 (Q2)
|
$0.14 | $0.04 | +0.0992 | +243.14% |
|
Mar 2025 (Q1)
|
$-0.14 | $-0.05 | -0.0924 | -194.12% |
|
Dec 2024 (Q4)
|
$0.02 | $0.08 | -0.0598 | -74.94% |
Financial Statements
| Revenues | $338.99M |
| Benefits Costs and Expenses | $267.16M |
| Costs And Expenses | $215.80M |
| Nonoperating Income/Loss | -$29.62M |
| Operating Expenses | $215.80M |
| Selling, General, and Administrative Expenses | $96.55M |
| Research and Development | $98.66M |
| Other Operating Expenses | $20.58M |
| Operating Income/Loss | $123.19M |
| Income/Loss From Continuing Operations After Tax | $28.55M |
| Income/Loss From Continuing Operations Before Tax | $71.83M |
| Income Tax Expense/Benefit | $65.02M |
| Net Income/Loss | $28.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $28.55M |
| Net Income/Loss Available To Common Stockholders, Basic | $28.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.17 |
| Diluted Earnings Per Share | $0.17 |
| Basic Average Shares | 161,915,000 |
| Diluted Average Shares | 178,331,000 |
| Assets | $396.06M |
| Current Assets | $273.84M |
| Noncurrent Assets | $122.22M |
| Fixed Assets | $3.67M |
| Other Non-current Assets | $118.55M |
| Liabilities | $660.22M |
| Current Liabilities | $242.50M |
| Accounts Payable | $1.61M |
| Wages | $10.63M |
| Other Current Liabilities | $230.27M |
| Noncurrent Liabilities | $417.72M |
| Long-term Debt | $199.51M |
| Other Non-current Liabilities | $218.21M |
| Equity | -$264.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$264.16M |
| Liabilities And Equity | $396.06M |
| Net Cash Flow From Operating Activities | $67.68M |
| Net Cash Flow From Operating Activities, Continuing | $67.68M |
| Net Cash Flow From Investing Activities | -$35.00K |
| Net Cash Flow From Investing Activities, Continuing | -$35.00K |
| Net Cash Flow From Financing Activities | -$14.79M |
| Net Cash Flow From Financing Activities, Continuing | -$14.79M |
| Net Cash Flow | $52.86M |
| Net Cash Flow, Continuing | $52.86M |
| Comprehensive Income/Loss | $28.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $28.89M |
| Other Comprehensive Income/Loss | $338.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $338.00K |